The FDA approved the first 3D-printed drug last week, Spritam (levetiracetam), which is used to treat certain types of seizures. 3D printing technology is able to manufacture formulations of medications so that they can address particular issues such as patient swallowing. The Sedgwick Connection blog addressed the potential for such technologies to play into the future of pharmaceutical distribution in comp and beyond with “patient specific care.” Dr. Paul Peak, Director Clinical Pharmacy, Complex Pharmacy Management at Sedgwick explains in the post: “Currently, if I need a prescription for antibiotics, my physician would select the right drug for the infection and prescribe one of a few strengths manufactured today. However, 3D drug printing technology could allow for specific drugs and strengths based on my weight, genetics, age, etc. That is, if 3D drug printers find their way from pharmaceutical companies to physicians’ offices or pharmacies, the ways to customize medications based on patient-specific needs would be endless.”
Read the full post on Sedgwick Connection here.